| Symbol |
Name |
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AR
|
androgen receptor
|
|
ATAD2
|
ATPase family, AAA domain containing 2
|
|
ATM
|
ATM serine/threonine kinase
|
|
AURKA
|
aurora kinase A
|
|
AXIN1
|
axin 1
|
|
AXIN2
|
axin 2
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BMP7
|
bone morphogenetic protein 7
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRD4
|
bromodomain containing 4
|
|
BTRC
|
beta-transducin repeat containing E3 ubiquitin protein ligase
|
|
CCAT1
|
colon cancer associated transcript 1 (non-protein coding)
|
|
CCNB1
|
cyclin B1
|
|
CCND1
|
cyclin D1
|
|
CCNT1
|
cyclin T1
|
|
CD33
|
CD33 molecule
|
|
CD34
|
CD34 molecule
|
|
CDCA7
|
cell division cycle associated 7
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDK6
|
cyclin-dependent kinase 6
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDX2
|
caudal type homeobox 2
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CEBPE
|
CCAAT/enhancer binding protein (C/EBP), epsilon
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CKS1B
|
CDC28 protein kinase regulatory subunit 1B
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CTCF
|
CCCTC-binding factor (zinc finger protein)
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CUL7
|
cullin 7
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
DCN
|
decorin
|
|
DDHD2
|
DDHD domain containing 2
|
|
DLX5
|
distal-less homeobox 5
|
|
E2F1
|
E2F transcription factor 1
|
|
E2F2
|
E2F transcription factor 2
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF3H
|
eukaryotic translation initiation factor 3, subunit H
|
|
EIF4B
|
eukaryotic translation initiation factor 4B
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
|
EP300
|
E1A binding protein p300
|
|
EP400
|
E1A binding protein p400
|
|
EPC1
|
enhancer of polycomb homolog 1 (Drosophila)
|
|
EPC2
|
enhancer of polycomb homolog 2 (Drosophila)
|
|
EPHA2
|
EPH receptor A2
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ESR1
|
estrogen receptor 1
|
|
ETV6
|
ets variant 6
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
FBXO28
|
F-box protein 28
|
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FHIT
|
fragile histidine triad
|
|
FLT4
|
fms-related tyrosine kinase 4
|
|
FOXO3
|
forkhead box O3
|
|
GATA4
|
GATA binding protein 4
|
|
GLS
|
glutaminase
|
|
GLTSCR2
|
glioma tumor suppressor candidate region gene 2
|
|
GNL3
|
guanine nucleotide binding protein-like 3 (nucleolar)
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
HAVCR2
|
hepatitis A virus cellular receptor 2
|
|
HDAC1
|
histone deacetylase 1
|
|
HDAC3
|
histone deacetylase 3
|
|
HES1
|
hes family bHLH transcription factor 1
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIST3H3
|
histone cluster 3, H3
|
|
HLX
|
H2.0-like homeobox
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HNRNPD
|
heterogeneous nuclear ribonucleoprotein D (AU-rich element RNA binding protein 1, 37kDa)
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HUWE1
|
HECT, UBA and WWE domain containing 1, E3 ubiquitin protein ligase
|
|
ID2
|
inhibitor of DNA binding 2, dominant negative helix-loop-helix protein
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IRF4
|
interferon regulatory factor 4
|
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
JAG2
|
jagged 2
|
|
JAK2
|
Janus kinase 2
|
|
KAT2A
|
K(lysine) acetyltransferase 2A
|
|
KAT5
|
K(lysine) acetyltransferase 5
|
|
KDM4B
|
lysine (K)-specific demethylase 4B
|
|
KDM5B
|
lysine (K)-specific demethylase 5B
|
|
KIAA1524
|
KIAA1524
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
|
KLF5
|
Kruppel-like factor 5 (intestinal)
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
LDHA
|
lactate dehydrogenase A
|
|
LDHB
|
lactate dehydrogenase B
|
|
MAFB
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog B
|
|
MAX
|
MYC associated factor X
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MINA
|
MYC induced nuclear antigen
|
|
MIR148A
|
microRNA 148a
|
|
MIR17HG
|
miR-17-92 cluster host gene
|
|
MIR22
|
microRNA 22
|
|
MIR23A
|
microRNA 23a
|
|
MIR23B
|
microRNA 23b
|
|
MIR26A1
|
microRNA 26a-1
|
|
MIR28
|
microRNA 28
|
|
MIR29A
|
microRNA 29a
|
|
MIR34A
|
microRNA 34a
|
|
MIR363
|
microRNA 363
|
|
MIR375
|
microRNA 375
|
|
MIR378A
|
microRNA 378a
|
|
MIR451A
|
microRNA 451a
|
|
MIR9-1
|
microRNA 9-1
|
|
MIRLET7C
|
microRNA let-7c
|
|
MLANA
|
melan-A
|
|
MST1
|
macrophage stimulating 1
|
|
MTBP
|
MDM2 binding protein
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MXD1
|
MAX dimerization protein 1
|
|
MXI1
|
MAX interactor 1, dimerization protein
|
|
MYBL2
|
v-myb avian myeloblastosis viral oncogene homolog-like 2
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
MYCT1
|
myc target 1
|
|
NDRG1
|
N-myc downstream regulated 1
|
|
NDRG2
|
NDRG family member 2
|
|
NFE2
|
nuclear factor, erythroid 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NKX3-1
|
NK3 homeobox 1
|
|
NMI
|
N-myc (and STAT) interactor
|
|
NOTCH1
|
notch 1
|
|
NUAK1
|
NUAK family, SNF1-like kinase, 1
|
|
OTX2
|
orthodenticle homeobox 2
|
|
PAK2
|
p21 protein (Cdc42/Rac)-activated kinase 2
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PEG10
|
paternally expressed 10
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIM1
|
Pim-1 proto-oncogene, serine/threonine kinase
|
|
PIM2
|
Pim-2 proto-oncogene, serine/threonine kinase
|
|
PLD1
|
phospholipase D1, phosphatidylcholine-specific
|
|
PML
|
promyelocytic leukemia
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PPIB
|
peptidylprolyl isomerase B (cyclophilin B)
|
|
PPP2R2B
|
protein phosphatase 2, regulatory subunit B, beta
|
|
PRDM1
|
PR domain containing 1, with ZNF domain
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
|
PRKCD
|
protein kinase C, delta
|
|
PROM1
|
prominin 1
|
|
PSIP1
|
PC4 and SFRS1 interacting protein 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6
|
|
PVT1
|
Pvt1 oncogene (non-protein coding)
|
|
RB1
|
retinoblastoma 1
|
|
REST
|
RE1-silencing transcription factor
|
|
RET
|
ret proto-oncogene
|
|
RHOA
|
ras homolog family member A
|
|
ROMO1
|
reactive oxygen species modulator 1
|
|
RUNX1
|
runt-related transcription factor 1
|
|
SAE1
|
SUMO1 activating enzyme subunit 1
|
|
SDC4
|
syndecan 4
|
|
SERPINB3
|
serpin peptidase inhibitor, clade B (ovalbumin), member 3
|
|
SIN3B
|
SIN3 transcription regulator family member B
|
|
SIRT1
|
sirtuin 1
|
|
SIRT7
|
sirtuin 7
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SMAD7
|
SMAD family member 7
|
|
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SP1
|
Sp1 transcription factor
|
|
SPHK2
|
sphingosine kinase 2
|
|
SPI1
|
Spi-1 proto-oncogene
|
|
SRSF1
|
serine/arginine-rich splicing factor 1
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STK38
|
serine/threonine kinase 38
|
|
SUPT3H
|
suppressor of Ty 3 homolog (S. cerevisiae)
|
|
TAF4B
|
TAF4b RNA polymerase II, TATA box binding protein (TBP)-associated factor, 105kDa
|
|
TAF9
|
TAF9 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 32kDa
|
|
TAL1
|
T-cell acute lymphocytic leukemia 1
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TERT
|
telomerase reverse transcriptase
|
|
TFAP2C
|
transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma)
|
|
TGFA
|
transforming growth factor, alpha
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
THBS1
|
thrombospondin 1
|
|
TIAL1
|
TIA1 cytotoxic granule-associated RNA binding protein-like 1
|
|
TOB2
|
transducer of ERBB2, 2
|
|
TOPBP1
|
topoisomerase (DNA) II binding protein 1
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TRPC4AP
|
transient receptor potential cation channel, subfamily C, member 4 associated protein
|
|
TRRAP
|
transformation/transcription domain-associated protein
|
|
TTC5
|
tetratricopeptide repeat domain 5
|
|
UBA2
|
ubiquitin-like modifier activating enzyme 2
|
|
USP22
|
ubiquitin specific peptidase 22
|
|
USP28
|
ubiquitin specific peptidase 28
|
|
UTF1
|
undifferentiated embryonic cell transcription factor 1
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
WNT1
|
wingless-type MMTV integration site family, member 1
|
|
WRN
|
Werner syndrome, RecQ helicase-like
|
|
YBX1
|
Y box binding protein 1
|
|
YEATS4
|
YEATS domain containing 4
|
|
YWHAB
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta
|
|
ZBTB16
|
zinc finger and BTB domain containing 16
|
|
ZBTB17
|
zinc finger and BTB domain containing 17
|
|
ZFP36
|
ZFP36 ring finger protein
|
|
ZNF703
|
zinc finger protein 703
|
